A combined approach for the early detection of ovarian cancer in asymptomatic women

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 65, Issue 2, 1996, Pages 221-225

  Adonakis, George L ^a   Paraskevaidis, Evangelos ^a   Tsiga, Stamatia ^b   Seferiadis, Konstantinos ^b   Lolis, Dimitrios E ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Ca 125; Ovarian cancer; Pelvic examination; Screening test

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; OVARY CANCER; PRIORITY JOURNAL; SYMPTOM;

EID: 0029881226     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-2115(95)02369-0     Document Type: Article

References (14)

1. Boring CC, Squires TS, Tong T. Cancer Statistics 1991. Cancer J Clin 1991; 41: 19-36.
2. Einhorn N, Nilsson B, Sjövall K. Factors influencing survival in carcinoma of the ovary. Cancer 1985; 55: 2019-2025.
3. Westhoff CL, Randal MC. Ovarian cancer screening: potential effect on mortality. Am J Obstet Gynecol 1991; 165: 502-505.
4. van Nagell JR Jr. Ovarian cancer screening. Cancer 1991; 68: 679-680.
5. Harlap S. The epidemiology of ovarian cancer. In: Markman M, Hoskin WJ, editors. Cancer of the ovary. New York: Raven Press, 1993; 79-93.
6. Jacobs I, Bridges J, Reynolds K, Stabile I, Kemsley P, Grudzinskas J et al. Multimodal approach to screening for ovarian cancer. Lancet 1988; i: 268-271.
7. Whittemore AS, Harris R, Hnyre J, Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of twelve US-case control studies. II. Invasive epithelial ovarian cancer in white women. Am J Epidemiol 1992; 136: 1184-1203.
8. Skates SJ, Singer DE. Quantifying the potential benefit of CA-125 screening for ovarian cancer. J Clin Epidemiol 1991; 44: 365-380.
9. Cambell S, Bhan V, Royston P, Whitehead MI, Collins WP. Transabdominal ultrasound screening for early ovarian cancer. Br Med J 1989; 299: 1363-1367.
10. De Priest PD, Van Nagelt JR, Gallion HH, Shenson D, Hunter JE, Andrews SJ et al. Ovarian cancer screening in asymptomatic postmenopausal women. Gynecol Oncol 1993; 51: 205-209.
11. Puls LE, Powell DE, De Priest PD, Gallion HH, Hunter JE, Kryscio RJ et al. Transition from benign to malignant epithelial in mucinous and serous ovarian cystadenocarcinoma. Gynecol Oncol 1992; 47: 53-57.
12. Jacobs IJ, Oram DH, Bast Jr. RC. Strategies for improving the specificity of screening for ovarian cancer with tumour-associated antigens CA 125, CA 15-3 and TAG 72.3. Obstet Gynecol 1992; 80: 396-399.
13. Kristen P, Dörffler P, Caffrer H. Clinical value of CASA vs. CA 125 in ovarian cancer. In: R. Klapdor, editor. Current tumor diagnosis, applications, clinical relevance, research, trends. München: W Zuckschwerdt Verlag, 1994; 280-284.
14. Kurjak KA, Zalud I, Alfirevic Z. Evaluation of adnexal masses with transvaginal color ultrasound. J Ultrasound Med 1991; 10: 295-297.